Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9861
-0.1139 (-10.35%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $47.92 million as of October 30, 2026. It is the 30,342nd most valuable company in the world and the 4,634th biggest in the United States. Its market cap has decreased by 32.82% in one year.
Market Cap
47.92M
Enterprise Value
25.94M
1-Year Change
-32.82%
Global Rank
Country Rank
#4,634 United States
Category
ChartMarket Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $47.92M, a decrease of -89.12%. That is a compound annual growth rate of -33.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 47.92M | 55.85% |
| Dec 31, 2025 | 30.75M | -53.38% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
| Apr 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| iBio, Inc. | 49.43M |
| Gain Therapeutics | 49.32M |
| Serina Therapeutics | 49.28M |
| Kalaris Therapeutics | 48.32M |
| Annovis Bio | 48.14M |
| LeonaBio | 46.54M |
| ImageneBio | 46.54M |
| Actinium Pharmaceuticals | 46.53M |